Ten priority drugs were approved in 2006, the FDA says, down five from 2005. The median review time remained unchanged at six months, down from 15.8 months in 2005. The number of new drugs filed for approval in 2006 was 29, down from 33 in 2005 and 32 in 2004.
From the May 01, 2007 Issue of MM+M - Medical Marketing and Media